Clinical Trial: Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy

U.S., June 27 -- ClinicalTrials.gov registry received information related to the study (NCT07671547) titled 'Prophylaxis of Hematologic Complications With Naderin in First-Line Breast Cancer Chemotherapy' on June 22.

Brief Summary: The goal of this clinical trial is to learn if Naderin works to prevent low white blood cell counts in people with breast cancer receiving first-line chemotherapy. The main questions it aims to answer are:

1. Does taking Naderin lower the number of people who get low white blood cell counts during chemotherapy?

2. Does taking Naderin help people finish all of their chemotherapy treatments without interruptions? Researchers will compare people who receive chemotherapy with Naderin to people who receive chemothe...